In accordance with relevant work arrangements and the requirements outlined in the Compilation Outline for the 2025 Edition of the Chinese Pharmacopoeia, the National Pharmacopoeia Commission proposes that the following 19 varieties will no longer be included in Part I of the 2025 Edition of the Chinese Pharmacopoeia: Fuke Tongjing Pills (妇科通经丸), Hufeng Wine (胡蜂酒), Jiusheng Powder (九圣散), Kangshuan Zaizao Pills (抗栓再造丸), Xiaoying Pills (消瘿丸), Wanling Wuxiang Plaster (万灵五香膏), Guilingji (龟龄集), Zhishou Huatan Pills (止嗽化痰丸), Awei Huapi Plaster (阿魏化痞膏), Tongru Granules (通乳颗粒), Tongbi Tablets (通痹片), Tongbi Capsules (通痹胶囊), Zaizao Pills (再造丸), Badu Plaster (拔毒膏), Zhuli Datan Pills (竹沥达痰丸), Jinpu Capsules (金蒲胶囊), Shexiang Naomaikang Capsules (麝香脑脉康胶囊), Yangdan Pills (羊胆丸), Huixiang Juhe Pills (茴香橘核丸)
This is hereby announced.
Contact Numbers: 010-67079538, 010-67079569
